Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cangene acquires rights to IB-1001

Feb. 7, 2013

Agreement entered into on phase II trial of universal factor Xa inhibitor antidote PRT-4445

Feb. 6, 2013

Merck Serono and Opexa Therapeutics enter MS drug agreement

Feb. 6, 2013

The Medicines Company and Alnylam to develop therapeutics for hypercholesterolemia

Feb. 5, 2013

Japanese government provides funding for unoprostone isopropyl development

Feb. 5, 2013

Vernalis' drug discovery collaboration with Genentech yields milestone payment

Feb. 4, 2013

Teva Pharmaceutical terminates agreements with CureTech

Feb. 4, 2013

Pharmaxis provides update on Bronchitol

Feb. 1, 2013

Phylogica receives milestone payment under collaboration with Janssen Biotech

Feb. 1, 2013

Ezose Sciences enters glycomics research agreement

Feb. 1, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026